We have observed
14 EP applications
Elizabeth Anne Drury
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after November 18, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS
METHODS OF TREATMENT AND PREVENTION OF EYE DISEASES
IMPROVED POXVIRAL VACCINES
PYRIDINE DERIVATIVES AS REARRANGED DURING TRANSFECTION (RET) KINASE INHIBITORS
NOVEL METHOD AND COMPOSITIONS
CRYSTALLINE FORMS OF 2-(4-(4-ETHOXY-6-OXO-1,6-DIHYDROPYRIDIN-3-YL)-2-FLUOROPHENYL)-N-(5-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)ISOXAZOL-3-YL)ACETAMIDE
NOVEL COMPOUNDS AS REARRANGED DURING TRANSFECTION (RET) INHIBITORS
PYRIDONE DERIVATIVES AS REARRANGED DURING TRANSFECTION (RET) KINASE INHIBITORS
SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS